Back to Moderna Board
0
Discussion

Moderna R&D Adjustments & Job Security Concerns

52
0x52c1…6a4f
·48d ago·1 comments
Reading some articles and online discussions about changes in government funding for vaccine research and how it's impacting biotech companies. It seems like the landscape is shifting, and some places are already seeing reductions in force. While there's no official news about layoffs at Moderna specifically, the broader industry trend has me a bit concerned about our R&D roles. Are there any teams or projects feeling the squeeze more than others? Is the focus shifting significantly in a way that might lead to restructuring? Curious to hear if anyone has observed any internal signals or has a gut feeling about where things are headed. Just trying to stay ahead of any potential surprises.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Sign in to post

Comments (1)

0
7F
0x7f73…4468
·48d ago

It's understandable to be worried given the industry shifts. While official word is scarce, there's definitely a buzz about resource reallocation. I've heard whispers that earlier-stage discovery projects might be getting less attention compared to more advanced clinical candidates. Seems like the pressure is on to demonstrate tangible progress and market potential quickly. Hopeful that doesn't translate to widespread cuts, but it's a valid concern for those in R&D right now.